ABSTRACT A new technique is described for treating patients with inoperable malignant tumours causing occlusion or stenosis of the trachea or main bronchi. High dose iridium-192 (20 Ci) was introduced by an afterloading device under computer control via a 4mm delivery tube into the tumour mass. In 29 of the 56 patients the tumour mass was canalised by a neodymium-YAG laser immediately before the afterloading delivery tube was introduced. In 44 (79%) of the patients, there was impressive relief of dyspnoea, accompanied by tumour regression observed at endoscopy and also by highly significant improvement in ventilatory function values, lung perfusion scans, and levels of arterial oxygen tension. In the other 12 patients (21%) there was no detectable improvement. The findings suggest that this recently developed combination treatment is of value in patients with advanced tumours of the trachea and main bronchi in whom there is no possibility of further treatment by external irradiation or repeated laser coagulation.
Introduction
The most important consideration in the palliative treatment of inoperable malignant tumours causing stenosis or occlusion of the trachea or main bronchi is the restoration of patency of the airway to relieve distress from dyspnoea.
Removal at endoscopy of as much of the tumour mass as possible by biopsy forceps, usually combined with cryosurgery,l electrocautery,2 or laser coagulation,36 can achieve only limited clearance since this is restricted by the bronchial wall, and therefore relief is usually short lived.
Irradiation offers the possibility of obtaining longer periods of remission. External palliative radiation is effective in the treatment of superior vena cava obstruction or haemoptysis, but is much less effective for treating occluded bronchi with associated atelectasis. reduced the exposure time for endobronchial irradiation to a few 20 minute periods. The treatment could be performed under local anaesthesia. Since, however, the afterloading catheter had to be introduced through a tube of 9mm internal diameter, it was impossible to place it in an optimal position of proximity to tumour that had nearly or completely occluded a bronchus.13
The technique described here overcomes this problem by using a delivery tube of only 4mm external diameter and 60 cm length directly under view by the flexible fibrescope. The procedure can be carried out under local anaesthesia. For tumours causing complete occlusion, laser coagulation by neodymium-YAG laser (MBB, Munich) was first performed to canalise the tumour mass so that the afterloading tube could be placed in an optimal position for irradiation of the whole tumour.
Our observations in 56 patients with central obstructing tumours who were treated by this new combination treatment form the basis of this report.
Patients and methods
Since June 1983 we have used this technique to treat 56 patients with inoperable tumours of the trachea and main bronchi. Dyspnoea was the predominant symptom in all the 56 patients (44 men, mean age 62-8 years; 12 women, mean age 71-1 years). Nineteen patients had previously been treated with external irradiation (mean dose 62 5 Gy (6250 rad)), of whom two had not tolerated the side effects of previous cytotoxic treatment and three others had had laser coagulation at rapidly decreasing intervals. The tumour was in the right main bronchus in 33 patients, in the left main bronchus in 20 patients, and in the trachea in three patients. In 25 patients there was atelectasis distal to the tumour. The most common tumour was squamous cell carcinoma, which occurred in 71 % of the men and 50% of the women. Five patients had adenoid-cystic carcinoma. Most of the tumours New technique for treating occlusive and stenosing tumours of the trachea and main bronchi and I -mm in diameter. Its active dimensions are 5S0 mm in length and 0 5 mm in diameter. The source capsule is welded to a stainless steel source cable that is moved by a high reliability friction drive. This mechanism in conjunction with a stepper motor moves the source precisely out of its shielding into the desired treatment position inside the applicator. The accuracy of the source is independently monitored. The maximum treatment distance is 20 cm. To achieve the appropriate isodose distribution the source can be moved in increments from I to 1Omm and the dwell time (from 0 to 1000 seconds) can be selected at each position.
In our investigation we used 5 mm steps and dwell times from 5 to 9 seconds, depending on the age of the iridium source. Figure 2 shows as an example the distribution of the isodose curves for an irradiation of a 6 cm area of the bronchus. By one treatment with this source 7 5 Gy are delivered from a 1O mm distant source, with a steep decrease in the amounts delivered with greater distances of the source. In case of main motor malfunction there is a supplementary emergency motor and in addition a handcrank for manual removal of this very active source from the patient in case of a breakdown of the complete electrical system (fig 3) . . ''. . .'. ' .
.} . ideally suited to the narrow bronchial system and can be adapted to its anatomy. Figure 4 shows a flexible bronchofibrescope (Olympus BF-1 T 10), together with the flexible applicator we used for endobronchial irradiation and in addition the quartz light cable of the neodymium-YAG laser. Three endobronchial treatments were given to each patient with an interval of 14 days between them. The clinical effect was then evaluated. In the further course of the disease additional treatments were required (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . In the 29 patients in whom there was occlusion of a main bronchus, the tumour was canalised by laser coagulation (1500-2000 J) immediately before the introduction of the afterloading catheter. Laser canalisation was performed on 52 of the 206 occasions on which the patients were treated.
Treatment was evaluated by assessment of the change of severity of dyspnoea, the endoscopic and radiographic findings and results of pulmonary function tests and lung perfusion scans and the levels of arterial oxygen tension (Pao2) after treatment. Conventional statistical tests of significance (Wilcoxon test and sign test) were used in the analyses.
Results
No patient had any major complication during thẽ~~~~~~~~~~~~~~~.
. . . . procedure. The only untoward occurrence was haemorrhage (more than 50 ml) in two patients owing to manipulation of the afterloading catheter. The bleeding was treated conservatively. There were no deaths during the procedure or in the immediate postoperative period of 10 days. In 44 (79%) of the 56 patients there was a reduction in the severity of dyspnoea. This subjective improvement was reflected in the endoscopy and tomography findings, tumour regression being found in 46 (82%) patients. In the 25 patients with atelectasis radiological evidence of reaeration was found in 22 (88%). Pulmonary function data before and after treatment were available in 20 patients. There were highly significant changes (p < 0 001) in the mean values of static vital capacity, FEVI, peak expiratory and inspiratory flow rates, and specific airway resistance (table 2). A significant improvement was also found in the perfusion of the affected relative to the unaffected lung and in mean arterial oxygen.
Judged by all criteria, a satisfactory result was obtained in 44 (79%) of the patients. No improvement occurred in the other 12 patients, all of whom died within a few weeks, the mean survival time being 11 weeks. During the two years of observation 37 of the 56 patients (66%) have died, four from massive haemorrhage and two from tracheo-oesophageal fistula. The mean survival time of the 19 patients who were still alive at the end of the observation period was 24 weeks.
Discussion
The chief advantage of the technique described here is that it makes it possible to deliver a high dose of radiation over a short and precisely controlled time to a limited area in the bronchial tree, with minimal damage to the surrounding lung tissue. Since whole body radiation is negligible, the treatment can be given repeatedly and in combination with external radiation and with cytotoxic treatment. We are greatly indebted to Dr Jan Gregg for his valuable comments on the manuscript.
